Stocks · News reference

HCW Biologics Says It Received USPTO Notice Of Allowance For Claims Covering Use Of HCW9302 To Treat Alopecia Areata; Says Phase 1 Monotherapy Study On Track For Q4 2026 Completion

Sep 2, 2026, 1:02 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 25, 2026, 1:02 PMBenzinga Newsdesk
HCW Biologics, Partners Identify TGF-β Trap, IL-15 Fusion As Novel Moiety With Potential Applications Against Diseased Cell, Viral Infections
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune
HCWB
BenzingaAug 18, 2026, 9:06 PMBenzinga Insights
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. The company's, Q2 earnings came
AHG APUS CRIS HCWB IMCC
BenzingaAug 14, 2026, 7:21 PMBenzinga Newsdesk
HCW Biologics Restates Q1 2026 EPS $1.39, Sales $6.543M Up From $5.065K YoY
HCWB